UB Paderborn / Katalog / Suche / in CDI

Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors

Clinical cancer research, 2016-02, Vol.22 (4), p.847-857

2016

Volltextzugriff (PDF)

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

Clinical cancer research, 2016-01, Vol.22 (1), p.34-43

2016

Volltextzugriff (PDF)

Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males

The journal of clinical endocrinology and metabolism, 2015-12, Vol.100 (12), p.4579-4587

2015

Volltextzugriff (PDF)

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML

Blood, 2018-03, Vol.131 (13), p.1415-1424

2018

Volltextzugriff (PDF)

Pharmacokinetics, pharmacodynamics and safety assessment of multiple doses of soticlestat in healthy volunteers

British journal of clinical pharmacology, 2022-06, Vol.88 (6), p.2899-2908

2022

Volltextzugriff (PDF)

The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial

European urology, 2020-08, Vol.78 (2), p.184-192

2020

Volltextzugriff (PDF)

A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation

Clinical pharmacokinetics, 2010-12, Vol.49 (12), p.799-816

2010

Volltextzugriff (PDF)

Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies

British journal of clinical pharmacology, 2019-11, Vol.85 (11), p.2568-2579

2019

Volltextzugriff (PDF)

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

Investigational new drugs, 2021-04, Vol.39 (2), p.488-498

2021

Volltextzugriff (PDF)

Morphological segmentation of FIB‐SEM data of highly porous media

Journal of microscopy (Oxford), 2013-05, Vol.250 (2), p.77-87

2013

Volltextzugriff (PDF)

Population pharmacokinetic analysis of varenicline in adult smokers

British journal of clinical pharmacology, 2009-11, Vol.68 (5), p.669-681

2009

Volltextzugriff (PDF)

3D Modelling of random cellulosic fibrous networks based on X-ray tomography and image analysis

Composites science and technology, 2005-10, Vol.65 (13), p.1931-1940

2005

Volltextzugriff (PDF)

Segmentation of 3D microtomographic images of granular materials with the stochastic watershed

Journal of microscopy (Oxford), 2010-07, Vol.239 (1), p.17-31

2010

Volltextzugriff (PDF)

Modelling mesoporous alumina microstructure with 3D random models of platelets

Journal of microscopy (Oxford), 2015-12, Vol.260 (3), p.287-301

2015

Volltextzugriff (PDF)

Revue compréhensive de l’apport de l’impression 3D en médecine : mise en perspective des différentes applications en urologie

Progrès en urologie (Paris), 2021-10, Vol.31 (12), p.762-771

2021

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Modeling of the Effect of Varenicline on Nicotine Craving in Adult Smokers

Nicotine & tobacco research, 2015-01, Vol.17 (1), p.106-113

2015

Volltextzugriff (PDF)

Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

Journal of clinical pharmacology, 2006-12, Vol.46 (12), p.1439-1448

2006

Volltextzugriff (PDF)

Effect of Human Renal Cationic Transporter Inhibition on the Pharmacokinetics of Varenicline, a New Therapy for Smoking Cessation: An In Vitro–In Vivo Study

Clinical pharmacology and therapeutics, 2008-04, Vol.83 (4), p.567-576

2008

Volltextzugriff (PDF)

Direct estimation of austenitic grain dimensions in heat affected zones of a martensitic steel from EBSD images

Journal of microscopy (Oxford), 2015-05, Vol.258 (2), p.87-104

2015

Volltextzugriff (PDF)

Utilisation de l’impression 3D avant néphrectomie partielle pour tumeur du rein

Progrès en urologie (Paris), 2020-11, Vol.30 (15), p.970-975

2020

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability After Single and Multiple Oral Doses of Varenicline in Elderly Smokers

Journal of clinical pharmacology, 2006-11, Vol.46 (11), p.1234-1240

2006

Volltextzugriff (PDF)

Single-Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

Journal of clinical pharmacology, 2006-09, Vol.46 (9), p.991-998

2006

Volltextzugriff (PDF)

Comprehensive review of 3D printing use in medicine: Comparison with practical applications in urology

Progrès en urologie (Paris), 2021-10, Vol.31 (12), p.762-771

2021

Volltextzugriff (PDF)

Use of personalized 3D printed kidney models for partial nephrectomy

Progrès en urologie (Paris), 2020-11, Vol.30 (15), p.970-975

2020

Volltextzugriff (PDF)

Apport de l’impression 3D à la chirurgie rénale mini-invasive : pour l’information préopératoire spécifique – patient et pour l’enseignement de la lecture du scanner–(UroCCR study no 39–3DPRINT)

Progrès en urologie (Paris), 2018-11, Vol.28 (13), p.674-675

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML

Pharmacokinetics, pharmacodynamics and safety assessment of multiple doses of soticlestat in healthy volunteers

The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial

A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation

Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

Morphological segmentation of FIB‐SEM data of highly porous media

Population pharmacokinetic analysis of varenicline in adult smokers

3D Modelling of random cellulosic fibrous networks based on X-ray tomography and image analysis

Segmentation of 3D microtomographic images of granular materials with the stochastic watershed

Modelling mesoporous alumina microstructure with 3D random models of platelets

Revue compréhensive de l’apport de l’impression 3D en médecine : mise en perspective des différentes applications en urologie

Pharmacokinetic-Pharmacodynamic Modeling of the Effect of Varenicline on Nicotine Craving in Adult Smokers

Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

Effect of Human Renal Cationic Transporter Inhibition on the Pharmacokinetics of Varenicline, a New Therapy for Smoking Cessation: An In Vitro–In Vivo Study

Direct estimation of austenitic grain dimensions in heat affected zones of a martensitic steel from EBSD images

Utilisation de l’impression 3D avant néphrectomie partielle pour tumeur du rein

Pharmacokinetics, Safety, and Tolerability After Single and Multiple Oral Doses of Varenicline in Elderly Smokers

Single-Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

Comprehensive review of 3D printing use in medicine: Comparison with practical applications in urology

Use of personalized 3D printed kidney models for partial nephrectomy

Apport de l’impression 3D à la chirurgie rénale mini-invasive : pour l’information préopératoire spécifique – patient et pour l’enseignement de la lecture du scanner–(UroCCR study no 39–3DPRINT)

Suchergebnisse filtern